Jul 27, 2016 - With the second quarter earnings season in full swing, several biotech companies including Amgen (AMGN) will be reporting this week.
Jul 26, 2016 - How will drug stocks like AMGN, GSK, VRTX and others, scheduled to report on Jul 27, fare this earnings season?
Jul 26, 2016 - Will Imbruvica and Humira help AbbVie (ABBV) deliver a positive earnings surprise in Q2?
Jul 26, 2016 - Alexion Pharmaceuticals (ALXN), which is set to report second-quarter 2016 results on Jul 28, had delivered a negative earnings surprise of 4.40% last quarter.
Jul 26, 2016 - Merck (MRK) had posted a positive earnings surprise in Q1. Will the stock deliver a positive surprise again this quarter?
Jul 26, 2016 - Focus will remain on the performance of ARIAD's (ARIA) leukemia drug, Iclusig.
Jul 25, 2016 - Amgen and Gilead Sciences are both reporting earnings this week. Which company is the better bet right now?
Jul 25, 2016 - Bristol-Myers Squibb (BMY), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.12% last quarter.
Jul 25, 2016 - Celgene Corporation (CELG), which is set to report second-quarter 2016 results on Jul 28, reported a positive earnings surprise of 12.38% last quarter.
Jul 25, 2016 - Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen